<?xml version="1.0" encoding="UTF-8"?>
<p>In a study by Valente et al. [
 <xref rid="B65-molecules-26-01093" ref-type="bibr">65</xref>], the potential of 
 <italic>D. carota subsp. gummifer</italic> EO as an antifungal and anti-inflammatory was evaluated against multiple collections and clinical strains via macrodilution broth assays. Among the tested strains were two 
 <italic>Candida</italic> strains isolated from recurrent cases of vulvovaginal candidosis (
 <italic>C. krusei</italic> H9 and 
 <italic>C. guillermondii</italic> MAT 23), three type strains from the American Type Culture Collection (
 <italic>C. albicans</italic> ATCC 10231, 
 <italic>C. tropicalis</italic> ATCC 13803, 
 <italic>C. parapsilosis</italic> ATCC 90018), one type strain from the Colección Española de Cultivos Tipo (
 <italic>C. neoformans</italic> CECT 1078), three dermatophyte strains isolated from nails and skin (
 <italic>T. mentagrophytes</italic> FF7, 
 <italic>M. canis</italic> FF1, 
 <italic>E. floccosum</italic> FF9), two type strains from CECT (
 <italic>T. rubrum</italic> CECT 2794, 
 <italic>M. gypseum</italic> CECT 2908), one 
 <italic>Aspergillus</italic> strain isolated from bronchial secretions (
 <italic>A. flavus</italic> F44) and two type strains from ATCC (
 <italic>A. niger</italic> ATCC 16404 and 
 <italic>A. fumigatus</italic> ATCC 46645). Chemical characterization of the oil revealed high amounts of monoterpenes with geranyl acetate and α-pinene as the major components. This EO action was shown to be active against dermatophytes and 
 <italic>C. neoformans</italic> (MIC range: 0.32–0.64 μL/mL). The promising results shown by this EO led to the recommendation of future studies with a specific emphasis on peripheral and central nervous systems (CNS), implying the need for in vivo research focused in dermatophytosis and inflammatory disease management [
 <xref rid="B65-molecules-26-01093" ref-type="bibr">65</xref>].
</p>
